The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol
Launched by UNIVERSITY OF PITTSBURGH · Apr 22, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Power Down Pilot Study is a research project designed to help children with autism, ages 6 to 10, who have trouble settling down to sleep. The study is testing a new bedtime routine called "The Power Down" to see if it is easy for parents to follow each night and if families find it helpful for their child's sleep issues. This study aims to gather feedback from families to understand if this approach works for them.
To participate, children must be between 6 and 10 years old and have a diagnosis of autism. Parents need to report that their child has difficulty settling down at bedtime and experiences sensory sensitivities. Families also need to be located near Pittsburgh and willing to follow the bedtime routine for two weeks. The study is not yet recruiting participants, but it is important for interested families to know that children with certain trauma histories or those who spend most nights at another caregiver's home may not be eligible. Overall, this study hopes to find effective ways to help autistic children get better sleep.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Child between the ages of 6 and 10 years old (at least 40%, no more than 60% female)
- • 2. Parent-reported autism diagnosis for child
- • 3. Parent-reported extended and problematic settling down delay
- • 4. Parent-reported sensory over-responsivity (a "yes" to at least 8 items in the sensory screening section of the checklist)
- • 5. Parent willing to participate in nightly routine during the 2 week study
- • 6. Located within the Pittsburgh area
- Exclusion Criteria:
- • 1. Participants will be excluded if they do not understand English or are unable to travel to University of Pittsburgh Medical Center Western Psychiatric Hospital.
- • 2. Children who have trauma or other histories for whom physical touch is triggering (per caregiver report) will be excluded.
- • 3. If a child spends bedtime at a different caregiver's home for \>50% of the nights and that caregiver is not willing to participate in this study, the child will be excluded from this study.
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Amy G Hartman, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported